Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T59875
(Former ID: TTDI03184)
|
|||||
Target Name |
Estrogen-related receptor-gamma (ESRRG)
|
|||||
Synonyms |
Nuclear receptor subfamily 3 group B member 3; NR3B3; KIAA0832; Estrogen-related receptor gamma; Estrogen receptor-related protein 3; ERRG2; ERR3; ERR gamma-2
Click to Show/Hide
|
|||||
Gene Name |
ESRRG
|
|||||
Target Type |
Literature-reported target
|
[1] | ||||
Function |
Binds specifically to an estrogen response element and activates reporter genes controlled by estrogen response elements. Induces the expression of PERM1 in the skeletal muscle. Orphan receptor that acts as transcription activator in the absence of bound ligand.
Click to Show/Hide
|
|||||
BioChemical Class |
Nuclear hormone receptor
|
|||||
UniProt ID | ||||||
Sequence |
MDSVELCLPESFSLHYEEELLCRMSNKDRHIDSSCSSFIKTEPSSPASLTDSVNHHSPGG
SSDASGSYSSTMNGHQNGLDSPPLYPSAPILGGSGPVRKLYDDCSSTIVEDPQTKCEYML NSMPKRLCLVCGDIASGYHYGVASCEACKAFFKRTIQGNIEYSCPATNECEITKRRRKSC QACRFMKCLKVGMLKEGVRLDRVRGGRQKYKRRIDAENSPYLNPQLVQPAKKPYNKIVSH LLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSL LQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMK LEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMT LPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV Click to Show/Hide
|
|||||
3D Structure | Click to Show 3D Structure of This Target | AlphaFold | ||||
HIT2.0 ID | T52NOH |
Cell-based Target Expression Variations | Top | |||||
---|---|---|---|---|---|---|
Cell-based Target Expression Variations |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Afimoxifene | Ligand Info | |||||
Structure Description | Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen | PDB:2GPU | ||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | No | [3] |
PDB Sequence |
YNKIVSHLLV
243 AEPEKIYAMP253 DPTVPDSDIK263 ALTTLCDLAD273 RELVVIIGWA283 KHIPGFSTLS 293 LADQMSLLQS303 AWMEILILGV313 VYRSLSFEDE323 LVYADDYIMD333 EDQSKLAGLL 343 DLNNAILQLV353 KKYKSMKLEK363 EEFVTLKAIA373 LANSDSMHIE383 DVEAVQKLQD 393 VLHEALQDYE403 AGQHMEDPRR413 AGKMLMTLPL423 LRQTSTKAVQ433 HFYNIKLEGK 443 VPMHKLFLEM453 LE
|
|||||
|
LEU265
4.075
LEU268
3.613
CYS269
3.843
LEU271
4.178
ALA272
3.386
ASP273
2.656
GLU275
2.604
LEU276
4.436
TRP305
3.575
MET306
3.905
LEU309
3.690
ILE310
4.467
VAL313
4.354
ARG316
3.421
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: Bisphenol A | Ligand Info | |||||
Structure Description | Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol A | PDB:2E2R | ||||
Method | X-ray diffraction | Resolution | 1.60 Å | Mutation | No | [4] |
PDB Sequence |
KPYNKIVSHL
241 LVAEPEKIYA251 MPDPTVPDSD261 IKALTTLCDL271 ADRELVVIIG281 WAKHIPGFST 291 LSLADQMSLL301 QSAWMEILIL311 GVVYRSLSFE321 DELVYADDYI331 MDEDQSKLAG 341 LLDLNNAILQ351 LVKKYKSMKL361 EKEEFVTLKA371 IALANSDSMH381 IEDVEAVQKL 391 QDVLHEALQD401 YEAGQHMEDP411 RRAGKMLMTL421 PLLRQTSTKA431 VQHFYNIKLE 441 GKVPMHKLFL451 EMLEAKVC
|
|||||
|
||||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Click to View More Binding Site Information of This Target with Different Ligands |
Different Human System Profiles of Target | Top |
---|---|
Human Similarity Proteins
of target is determined by comparing the sequence similarity of all human proteins with the target based on BLAST. The similarity proteins for a target are defined as the proteins with E-value < 0.005 and outside the protein families of the target.
A target that has fewer human similarity proteins outside its family is commonly regarded to possess a greater capacity to avoid undesired interactions and thus increase the possibility of finding successful drugs
(Brief Bioinform, 21: 649-662, 2020).
Biological Network Descriptors
of target is determined based on a human protein-protein interactions (PPI) network consisting of 9,309 proteins and 52,713 PPIs, which were with a high confidence score of ≥ 0.95 collected from STRING database.
The network properties of targets based on protein-protein interactions (PPIs) have been widely adopted for the assessment of target’s druggability. Proteins with high node degree tend to have a high impact on network function through multiple interactions, while proteins with high betweenness centrality are regarded to be central for communication in interaction networks and regulate the flow of signaling information
(Front Pharmacol, 9, 1245, 2018;
Curr Opin Struct Biol. 44:134-142, 2017).
Human Similarity Proteins
Biological Network Descriptors
|
There is no similarity protein (E value < 0.005) for this target
|
Degree | 1 | Degree centrality | 1.07E-04 | Betweenness centrality | 0.00E+00 |
---|---|---|---|---|---|
Closeness centrality | 2.03E-01 | Radiality | 1.35E+01 | Clustering coefficient | 0.00E+00 |
Neighborhood connectivity | 5.20E+01 | Topological coefficient | 1.00E+00 | Eccentricity | 11 |
Download | Click to Download the Full PPI Network of This Target | ||||
Chemical Structure based Activity Landscape of Target | Top |
---|---|
Drug Property Profile of Target | Top | |
---|---|---|
(1) Molecular Weight (mw) based Drug Clustering | (2) Octanol/Water Partition Coefficient (xlogp) based Drug Clustering | |
|
||
(3) Hydrogen Bond Donor Count (hbonddonor) based Drug Clustering | (4) Hydrogen Bond Acceptor Count (hbondacc) based Drug Clustering | |
|
||
(5) Rotatable Bond Count (rotbonds) based Drug Clustering | (6) Topological Polar Surface Area (polararea) based Drug Clustering | |
|
||
"RO5" indicates the cutoff set by lipinski's rule of five; "D123AB" colored in GREEN denotes the no violation of any cutoff in lipinski's rule of five; "D123AB" colored in PURPLE refers to the violation of only one cutoff in lipinski's rule of five; "D123AB" colored in BLACK represents the violation of more than one cutoffs in lipinski's rule of five |
Target Regulators | Top | |||||
---|---|---|---|---|---|---|
Target-regulating microRNAs | ||||||
Target-interacting Proteins |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Mol Cancer Res. 2003 Nov;1(13):981-91. | |||||
REF 2 | Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRbeta and ERRgamma. J Med Chem. 2005 May 5;48(9):3107-9. | |||||
REF 3 | X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation. J Biol Chem. 2006 Dec 8;281(49):37773-81. | |||||
REF 4 | Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma. J Biochem. 2007 Oct;142(4):517-24. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.